- Haemonetics Prices Upsized Private Placement of $600 Million Convertible Senior Notes
- Haemonetics Announces Proposed Convertible Senior Notes Offering
- Haemonetics 4th Quarter and Fiscal Year 2024 Earnings Release Available on Investor Relations Website
- Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024
- Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge
- Haemonetics Corporation Completes Acquisition of Attune Medical
More ▼
Key statistics
As of last trade Haemonetics Corp (HAE:NYQ) traded at 86.09, -12.13% below its 52-week high of 97.97, set on May 15, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 84.80 |
---|---|
High | 86.72 |
Low | 84.80 |
Bid | 86.04 |
Offer | 86.09 |
Previous close | 85.00 |
Average volume | 1.09m |
---|---|
Shares outstanding | 50.84m |
Free float | 50.45m |
P/E (TTM) | 36.76 |
Market cap | 4.27bn USD |
EPS (TTM) | 2.29 USD |
Data delayed at least 15 minutes, as of Jun 04 2024 16:13 BST.
More ▼